Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Elanco Animal Health Inc (ELAN)Equibles does not estimate personal net worth.
Get an email with a short summary when Elanco Animal Health Inc publishes a filing, an earnings call transcript or a press release.
Get ELAN alertsTiffany Kanaga is recorded as Head of Investor Relations at Elanco Animal Health Inc (ELAN). Tiffany Kanaga has spoken on 9 earnings calls across 1 company, most recently for Elanco Animal Health Inc on August 5, 2026. Elanco Animal Health Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Elanco Animal Health Inc includes Jeffrey N. Simmons (CEO and Board Member), Jeffrey Simmons (CEO and Board Member), Robert (Bob) VanHimbergen (CFO) and 7 others.
“Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer, Bob Van Himbergen, our Chief Financial Officer, and Beth Haney from Investor Relations.”
“Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer, Bob Van Himbergen, our Chief Financial Officer, and Beth Haney from Investor Relations.”
“Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Bob VanHimbergen, our Chief Financial Officer; and Beth Haney from Investor Relations.”
“Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Bob VanHimbergen, our Chief Financial Officer; and Beth Haney from Investor Relations.”
“Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; and Beth Haney from Investor Relations.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations